ZCA1 tcrb-Q (O1); june 18-19, 2019; DR. Jeffrery declue; bethesda north marriott; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012
Ended Awarded Last action
- Contract number
- 75N91019F00144
- Awardee
-
Bsrep II MBN LLC UEI TRP2FSD3MF43
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,396
Award facts
- Contract value 100% obligated
- $14,395.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 721110 Hotels (except Casino Hotels) and Motels
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,866 | |
| Original award | $18,262 |
About this award
The National Cancer Institute awarded a $14,395.98 blanket purchase agreement (BPA) call to Bsrep II MBN LLC, doing business as Bethesda North Marriott Hotel & Conference Center, for a scientific peer review meeting held on June 18-19, 2019, in Bethesda, Maryland. The contract, which carried an ultimate completion date of March 26, 2024, was structured as a firm fixed-price award with no set-aside designation, indicating the vendor competed on a standard competitive basis. The award covered hotel accommodations and conference facilities for the ZCA1 TCRB-Q meeting led by Dr. Jeffrey Declue at the Bethesda North Marriott, with total costs complying with HHS policy on efficient spending standards.
Bethesda North Marriott Hotel & Conference Center, a Marriott International subsidiary based in North Bethesda, Maryland, maintains an extensive track record supporting federal scientific meetings and conferences. The company has been registered in SAM.gov since February 2005 and regularly provides conference spaces, lodging, audiovisual equipment, and related hospitality services to National Institutes of Health institutes, including the National Cancer Institute and Center for Scientific Review. The contract was subsequently de-obligated in December 2023 as part of NIH Office of Administrative and Management Services fund management procedures related to expiring FY2019 budget lines.
Quick answers
Who was awarded contract 75N91019F00144?
75N91019F00144 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on June 18, 2019.
How much is contract 75N91019F00144 worth?
The government has obligated $14,396 on 75N91019F00144.
Is contract 75N91019F00144 an order under another contract?
Yes. 75N91019F00144 is a BPA call under HHSN263201500186B, a blanket purchase agreement.
Was contract 75N91019F00144 competed?
The extent of competition for 75N91019F00144 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award